Item 8.01. Other Events.

On January 13, 2021, Eloxx Pharmaceuticals, Inc. (the "Company") issued a press release announcing an expansion of its agreement with the Cystic Fibrosis Foundation beyond the U.S. portion of the Company's clinical trials to include additional funding for the global clinical trial program which includes Europe and Israel. The expanded agreement provides for additional funding of up to $2 million based on achievement of certain milestones. A copy of the Company's press release is being furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.



  99.1     Press Release dated January 13, 2021.
104      Inline XBRL for the cover page of this Current Report on Form 8-K

© Edgar Online, source Glimpses